openPR Logo
Press release

Parenteral Drug Market Financial Status over Forecast Period 2018 to 2028(Segmentation by Product Type Antibiotics Antineoplastic drug Anti-diabetic Drugs Analgesics Anti-inflammatory Drugs Anesthetics Others)

05-06-2019 08:28 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Parenteral Drug Market Financial Status over Forecast Period

Parenteral drugs are called the dosage forms that are intended for administration of medicine as injection or infusion. Parenteral form refers to administration of medications skipping the digestive system, rather injected or infused via intravenous or intramuscular mode of delivery. There are four most common delivery routes for parenteral drug administration including intravenous (IV) route, intraosseous infusion, subcutaneous route and intramuscular route. In Intravenous route of drug delivery, medicines or medicinal fluids are directly injected into patient's vein. However, subcutaneous parenteral drug is given under the skin and intramuscular parenteral drug is injected into muscle. The intravenous (IV) administration route for parenteral drug delivery is highly preferred over other delivery routes. Though solid dosage medicinal products are still prevailing in the market, parenteral drugs despite being a small molecule or a biologic-based drug is expected to increase their revenue share in the overall drug market.

The increasing approval for new parenteral drug across the globe is projected to propel parenteral drug market revenue growth over the forecast years. For instance, in 2016, 22 New Molecular Entities (NMEs) were approved by the US Food and Drug Administration’s Center for Drug Evaluation and Research. 13, or say 59 percent of these 22 NMEs approved were registered to be parenteral drugs. The increase in product launch activities for parenteral drugs by leading manufacturers such as Eli Lilly and Company, Biogen Inc., Merck and others. With the increasing rise in development of biologic-based drugs, the number of parenteral drugs that are under development or are getting FDA approval is anticipated to increase, thereby being one of the most prominent factor fueling the growth of parenteral drug market. However, high costs associated with the parenteral drug is restraining the revenue growth in parenteral drug market.

The parenteral drug market is categorized based on drug class, route of administration and distribution channel. Based on drug class, the parenteral drug are classified into six major drug classes. Out of the six major drug class, antibiotics are the most preferred parenteral drug type.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3189

The global parenteral drug market is segmented on basis of product type, material type, application type, end user and geographic region:

Segmentation by Product Type

Antibiotics
Antineoplastic drug
Anti-diabetic Drugs
Analgesics
Anti-inflammatory Drugs
Anesthetics
Others
Segmentation by Route of Administration

Intravenous (IV)
Subcutaneous (subQ)
Intramuscular (IM)
Intradermal
Segmentation by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
On the basis of product type, antibiotics parenteral drug segment is anticipated to expand its growth at a highest CAGR over the forecast years on the account of more demand for antibiotics from end use segments. However, the analgesics and anesthetics parenteral drug segment cumulatively holds the highest revenue share in parenteral drug market. Also, anti-inflammatory parenteral drug generates more revenue when compared to anti-diabetic parenteral drug. However, an upsurge in demand for Anti-diabetic parenteral drug is expected to exist in global parenteral drug market over the forecast period. Also, based on route of administration, parenteral drug are majorly injected via intravenous route. Hospital pharmacies followed by retail pharmacies is expected to register highest revenue growth rate during the forecast period.

North America and Europe cumulatively are expected to register highest market revenue share in global parenteral drug market due to the increased patient pool in the regions along with presence of top manufacturing companies across the region. The launch of new parental drug after FDA approval in the U.S. market enables North America to capture highest revenue share in parenteral drug market. Asian countries due to strong footprint for pharmaceutical companies entirely focused on production of parenteral drug allows Asia Pacific to grow at a significant CAGR over the forecast period.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3189

Some of the major key manufacturers involved in global parenteral drug market are Eli Lilly and Company, Biogen Inc., Merck & Co., Sanofi, Novo Nordisk, AbbVie, Intercept Pharmaceuticals, Jazz Pharmaceuticals, Teva Pharmaceuticals and others.

The report covers exhaustive analysis on:

Parenteral Drug Market Segments
Parenteral Drug Market Dynamics
Historical Actual Market Size, 2012 - 2016
Parenteral Drug Market Size & Forecast 2016 to 2024
Parenteral Drug Market Current Trends/Issues/Challenges
Competition & Companies involved
Parenteral Drug Market Drivers and Restraints
Regional analysis includes:

North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Report Analysis@ https://www.factmr.com/report/3189/parenteral-drug-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parenteral Drug Market Financial Status over Forecast Period 2018 to 2028(Segmentation by Product Type Antibiotics Antineoplastic drug Anti-diabetic Drugs Analgesics Anti-inflammatory Drugs Anesthetics Others) here

News-ID: 1727751 • Views: 347

More Releases from Fact.MR

Ready Meal Trays’ Myriad Applications and Recyclability Spearheading the Food …
The ready meal trays market continues to showcase stunning prospects, with overall incremental opportunity of over US$ 1.7 Billion by 2027 from 2019, according to a recent Fact.MR study. Growth in consumption of packaged food products across both developed as well as developing countries is anticipated to increase the demand for ready meal trays during the forecast period. Ready meal trays are increasingly used by food processors and fast service
Automation Making Significant Strides in the Container Handling Equipment Market …
According to a new Fact.MR study, the global market for container handling equipment is expected to increase at a value CAGR of 4.2% over the forecast period, to reach a market size of USD 2,316.6 Mn by 2029 from a calculated USD 1,541.2 Mn in 2019. The report provides potential takeaways that prove to be significantly useful for other market entrants in the container handling equipment market and evaluates trends
The Use of Automotive Actuators in Industrial Control Systems Will Bolster the A …
Fact.MR has recently published a report on the automotive actuators market. According to the report, in terms of revenue, the global automotive actuators market is estimated to expand at a CAGR of ~ 6.2% by value and ~ 5.2% by volume over the forecast period. Since the sales of automotive actuators is related to automotive production and vehicle parc, the increasing automotive production and vehicle parc across the globe is
Rising Inclination for Sustainable Packaging Solutions in F&B Sector Motivating …
Fact.MR has recently published a latest assessment report on Blow Molded Containers Market, which discourses prime facets associated to the global blow molded containers market. At present, the proliferation of sustainable food & beverage packaging applications at the global scale has been conveniently supporting sales of blow molded containers. Furthermore, the report predicts an average annual growth of roughly 5.7% in the global blow molded containers market during the stated

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning